A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2007
12/05/2007	CN100352425C Thin plaster, plaster thinning making method and apparatus
12/05/2007	CN100352424C Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel
12/05/2007	CN100352418C Base for oral composition and the oral composition
12/05/2007	CN100352379C Nutritious liquor (drink) for relieving the effect of alcohol, alcohol relieving capsule production method
12/04/2007	US7304201 Phototherapy bandage
12/04/2007	US7304122 Useful as carriers of drugs or other bioactive substances; polymers can be linked, intermixed, or a combination thereof, to one or more drugs
12/04/2007	US7304075 Aqueous solution of sitafloxacin and sodium chloride; photostable microorganisms
12/04/2007	US7304053 Glycoprotein-mediated MDR
12/04/2007	US7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
12/04/2007	US7304039 Glucose-based compounds with affinity to P-selectin
12/04/2007	US7304035 Stimulation of bone growth with thrombin peptide derivatives
12/04/2007	US7303768 Gastrointestinal disorders; antiulcer agents
12/04/2007	US7303767 Amorphous metal silicate, especially calcium silicate, coated with a hydrophilic material and a vehicle or an antiperspirant salt; cosmetic formulations with excellent odor neutralization and sebum absorption properties
12/04/2007	US7303766 Particularly calcium silicate with a hydrophilic coating, e.g., carboxymethylcellulose or chitosan; exhibits excellent odor neutralization and sebum absorption properties; used in cosmetic and/or personal care formulations
12/04/2007	US7303765 Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/04/2007	US7303764 For therapy of psychosis, acute mania or mild anxiety states
12/04/2007	US7303763 Noncracking complex; stability
12/04/2007	US7303762 Absorption enhancers
12/04/2007	US7303761 Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
12/04/2007	US7303760 Method for treating multi-drug resistant tumors
12/04/2007	US7303759 Applying gel to injury; curing
12/04/2007	US7303756 Multiphase system
12/04/2007	US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
12/04/2007	US7303674 Forward osmosis pressurized device and process for generating potable water
12/04/2007	US7302913 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
12/04/2007	CA2276170C Sustained analgesia achieved with buprenorphine
12/04/2007	CA2265815C Formulations for topical use
12/04/2007	CA2265767C Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
12/04/2007	CA2263705C Novel sandwich liposome complexes comprising a biologically active agent
12/04/2007	CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007	CA2253358C Powder containing reversed vesicles comprising one or more non-ionic surfactants
12/04/2007	CA2239313C Solid compound, its preparation and use in medicine
12/04/2007	CA2230950C Solid drug forms obtainable by extrusion of an isomalt-containing polymer/active ingredient melt
12/04/2007	CA2223894C Dinucleotides useful for the treatment of lung disease
12/04/2007	CA2201121C Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
12/04/2007	CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof
12/04/2007	CA2192965C Anandamide analogue compositions and method of treating intraocular hypertension using same
12/04/2007	CA2169608C Medical gas mixture
11/2007
11/30/2007	CA2591352A1 Treatment for herpes simplex virus and other infectious diseases
11/29/2007	WO2007137216A2 Gastroretentive sustained release formulations
11/29/2007	WO2007137040A2 7-(acryloyl) indole compositions and methods for making and using same
11/29/2007	WO2007136830A2 Process for producing nanoparticles by spray drying
11/29/2007	WO2007136664A2 Antibiotic formulation and method of treatment
11/29/2007	WO2007136663A2 Antibiotic/bone morphogenic protein formulation and method of treatment
11/29/2007	WO2007136633A2 Gel-formulations of hydrophobic photosensitizers for mucosal applications
11/29/2007	WO2007136219A1 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
11/29/2007	WO2007136151A1 Matrix tablets providing an extended release of metformin
11/29/2007	WO2007136134A1 Process for producing polymer micelle enclosing hydrophobic drug
11/29/2007	WO2007136129A1 Oral preparation comprising pioglitazone
11/29/2007	WO2007135774A1 Oral liquid preparation composition containing herbal medicine
11/29/2007	WO2007135766A1 Ointment for amelioration or treatment of oral tumor
11/29/2007	WO2007135523A2 A composition for inactivating an enveloped virus
11/29/2007	WO2007135470A1 Process for the preparation and surface coating of pellets
11/29/2007	WO2007135409A1 Particulate drug and drug compositions and their uses
11/29/2007	WO2007135362A2 Stable aqueous suspension having palatable taste
11/29/2007	WO2007135210A1 Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes
11/29/2007	WO2007135193A2 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
11/29/2007	WO2007135177A1 Production of enveloped pharmaceutical dosage forms
11/29/2007	WO2007135172A2 Cladribine regimen for treating multiple sclerosis
11/29/2007	WO2007135164A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
11/29/2007	WO2007134968A1 Inhalant aerosol formulations containing ethanol
11/29/2007	WO2007134967A1 Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007	WO2007134966A1 Inhalant propellant-free aerosol formulation
11/29/2007	WO2007134965A1 Aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007	WO2007134870A1 Bilayer tablet for preventing cardiovascular events
11/29/2007	WO2007134845A2 Olanzapine pharmaceutical composition
11/29/2007	WO2007134819A1 Cationic liposomal preparations for the treatment of rheumatoid arthritis
11/29/2007	WO2007134534A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF
11/29/2007	WO2007134533A1 20(R)-GINSENOSIDE Rg3 MEDICINAL SOLUBLE INTERMEDIATE AND PROCESS THEREOF
11/29/2007	WO2007134354A1 Pharmaceutical formulation
11/29/2007	WO2007114904A3 Cosmetic and therapeutic stick products comprising microparticles
11/29/2007	WO2007112107A3 Synthetic lipid rafts and methods of use
11/29/2007	WO2007104748A3 Improved process for producing a solid dispersion of an active ingredient
11/29/2007	WO2007104747A3 Process for producing a solid dispersion of an active ingredient
11/29/2007	WO2007100466A3 Nanoparticulate carvedilol formulations
11/29/2007	WO2007095342A3 Stable corticosteroid mixtures
11/29/2007	WO2007090255A3 Polymeric implant and a process for obtaining a polymeric implant
11/29/2007	WO2007089670A3 Enterically coated cysteamine, cystamine and derivatives thereof
11/29/2007	WO2007085902A3 Foamable composition combining a polar solvent and a hydrophobic carrier
11/29/2007	WO2007084266A3 Silicone adhesive for adhesion to wet surfaces
11/29/2007	WO2007076295A3 Nanoclusters for delivery of therapeutics
11/29/2007	WO2007073888A3 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
11/29/2007	WO2007072233A3 Improved mimosa tenuiflora extracts, methods for its obtaining and use for the treatment of ulcers in mammals
11/29/2007	WO2007053729A3 High load particles for inhalation having rapid release properties
11/29/2007	WO2007053197A3 Nanoparticulate acetaminophen formulations
11/29/2007	WO2007041367A3 Oral composition containing a salivation inducing agent
11/29/2007	WO2006115770A3 Orally disintegrating pharmaceutical tablet formulations of olanzapine
11/29/2007	WO2006112958A3 Methods and compositions for modified release of nutritional supplements
11/29/2007	WO2006096906A8 Inhalable drug
11/29/2007	WO2003067952A3 Glucosamine-polyacrylate inter-polymer complex and applications thereof
11/29/2007	US20070276481 Drug delivery device
11/29/2007	US20070276083 Luster material-containing resin composition
11/29/2007	US20070276035 Treatment of neurotic disorders
11/29/2007	US20070276033 ascorbic acid compositions that stabilize unusually large concentrations of vitamin C and vitamin E
11/29/2007	US20070276029 Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution
11/29/2007	US20070276015 Crystal modification of torasemide
11/29/2007	US20070276007 Administration of pharmaceuticals
11/29/2007	US20070276004 Pharmaceutical Composition Comprising an Immunosuppressant for Use in the Treatment of Skin Diseases
11/29/2007	US20070275991 Drug Delivery From Embolic Agents
11/29/2007	US20070275969 Nanoparticles for oral administration of pharmaceutical agents of low solubility

1 ... 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 ... 2991